Improve walking with robotic treadmill
- Trial ID
- NCT04087031
- Official Title
- Assistive Robotic in the Elderly: Innovative Models in the Rehabilitation of the Elderly With Parkinson's Disease Through Technological Innovation
- Goal
- Improve walking with robotic treadmill
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Istituto Nazionale di Ricovero e Cura per Anziani
- Study Type
- INTERVENTIONAL
- Enrollment
- 195 participants
- Conditions
- Parkinson Disease, Frail Elderly, Robotic Devices in Rehabilitation
- Interventions
- control arm, virtual reality games, robotic treadmill
Plain-Language Summary
The goal is to help frail older people with Parkinson's improve walking, balance, and independence, and to reduce falls and mobility-related dependence. The approach uses a robotic treadmill that supports and guides walking while interactive virtual reality games prompt stepping, weight shifts, and cognitive engagement to retrain gait patterns and build endurance; participants keep their usual Parkinson's medications but must have a stable drug regimen for at least one month. Looking for people 65 and older with mild to moderate Parkinson's, Hoehn and Yahr stage 1 to 3, reduced walking ability, ability to give consent, and no severe dementia or uncontrolled cardiac, autonomic, seizure, or other serious illnesses.
Locations
- IRCCS INRCA Hospital, Ancona, Italy
- IRCCS INRCA Hospital, Fermo, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying control arm. The goal is to help frail older people with Parkinson's improve walking, balance, and independence, and to reduce falls and mobility-related dependence. The approach uses a robotic treadmill that supports and guides walking while interactive virtual reality games prompt stepping, weight shifts, and cognitive engagement to retrain gait patterns and build endurance; participants keep their usual Parkinson's medications but must have a stable drug regimen for at least one month. Looking for people 65 and older with mild to moderate Parkinson's, Hoehn and Yahr stage 1 to 3, reduced walking ability, ability to give consent, and no severe dementia or uncontrolled cardiac, autonomic, seizure, or other serious illnesses.
- Who can participate?
- Participants must be at least 65 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 7 years and 1 month.